Skip to main content

China Universal Asset Management Co., Ltd.

Source: SEC Form 13F · as of Mar 2026

China Universal Asset Management Co., Ltd. holds 147 biotech & pharma companies tracked by BioSniper, totaling $141.1M in value as of Mar 2026 (SEC Form 13F).

Companies held

147

Total value held

$141.1M

BioSniper AIPage evidence connected

Prepared research question

What matters most for GILEAD SCIENCES, INC. (GILD)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
GILDGILEAD SCIENCES, INC.157,523$22.0M
REGNREGENERON PHARMACEUTICALS, INC.21,361$16.5M
ALNYALNYLAM PHARMACEUTICALS, INC.27,266$9.0M
INSMINSMED Inc47,015$7.7M
IONSIONIS PHARMACEUTICALS INC77,315$5.8M
ARGXARGENX SE5,035$3.7M
MRNAModerna, Inc.70,085$3.6M
ROIVRoivant Sciences Ltd.127,007$3.5M
RVMDREVOLUTION MEDICINES, INC.35,167$3.4M
INCYIncyte Corp.35,317$3.3M
SMMTSummit Therapeutics Inc.137,596$2.6M
BBIOBridgeBio Pharma, Inc.34,403$2.6M
SNYSanofi43,433$2.1M
JAZZJazz Pharmaceuticals plc10,924$2.1M
EXELEXELIXIS, INC.46,087$2.0M
BMRNBIOMARIN PHARMACEUTICAL INC34,129$1.9M
ONCBeOne Medicines Ltd.5,672$1.7M
PTGXProtagonist Therapeutics, Inc14,923$1.6M
ARWRARROWHEAD PHARMACEUTICALS, INC.24,850$1.6M
AXSMAxsome Therapeutics, Inc.9,078$1.5M
PCVXVaxcyte, Inc.25,540$1.5M
CYTKCYTOKINETICS INC21,856$1.4M
ABVXAbivax SA12,903$1.4M
IBRXImmunityBio, Inc.182,447$1.4M
NAMSNEWAMSTERDAM PHARMA CO N.V.43,703$1.4M
NUVLNuvalent, Inc.12,987$1.3M
COGTCogent Biosciences, Inc.28,803$1.1M
RYTMRHYTHM PHARMACEUTICALS, INC.12,118$1.1M
PTCTPTC THERAPEUTICS, INC.14,689$1.0M
TERNTerns Pharmaceuticals, Inc.18,869$995K
IMVTImmunovant, Inc.37,718$937K
APLSApellis Pharmaceuticals, Inc.22,684$913K
SRRKScholar Rock Holding Corp18,102$890K
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)16,000$889K
CNTACentessa Pharmaceuticals plc21,225$843K
APGEApogee Therapeutics, Inc.9,731$819K
DNLIDenali Therapeutics Inc.40,643$780K
LGNDLigand Pharmaceuticals Incorporated3,539$707K
SYRESpyre Therapeutics, Inc.13,938$703K
ACADACADIA PHARMACEUTICALS INC30,256$673K
GPCRStructure Therapeutics Inc.13,824$666K
TVTXTravere Therapeutics, Inc.19,825$589K
IRONDisc Medicine, Inc.8,372$535K
SUPNSUPERNUS PHARMACEUTICALS, INC.10,175$526K
ARQTArcutis Biotherapeutics, Inc.22,011$519K
TNGXTango Therapeutics, Inc.23,900$500K
ALMSALUMIS INC.22,436$494K
STOKStoke Therapeutics, Inc.15,136$493K
BEAMBeam Therapeutics Inc.18,075$431K
NTLAIntellia Therapeutics, Inc.33,464$429K
ORKAOruka Therapeutics, Inc.8,591$421K
KODKodiak Sciences Inc.10,834$413K
ELVNEnliven Therapeutics, Inc.10,532$413K
ADPTAdaptive Biotechnologies Corp28,925$401K
DAWNDay One Biopharmaceuticals, Inc.18,331$393K
KNSAKiniksa Pharmaceuticals International, plc8,145$392K
DFTXDefinium Therapeutics Inc.20,192$382K
ADMAADMA BIOLOGICS, INC.42,263$381K
DSGNDesign Therapeutics, Inc.35,109$374K
MAZEMaze Therapeutics, Inc.11,995$358K
AGIOAGIOS PHARMACEUTICALS, INC.10,398$352K
ANABANAPTYSBIO, INC6,164$342K
ZYMEZymeworks Inc.13,280$333K
OCULOCULAR THERAPEUTIX, INC38,631$327K
IMCRImmunocore Holdings plc10,783$325K
PHVSPharvaris N.V.11,367$321K
ANNXAnnexon, Inc.57,683$320K
SIONSionna Therapeutics, Inc.7,920$318K
GMABGenmab A/S11,424$307K
INVAInnoviva, Inc.13,145$306K
ANIPANI PHARMACEUTICALS INC3,978$306K
VCELVericel Corp9,008$290K
NKTRNEKTAR THERAPEUTICS4,000$288K
RXRXRECURSION PHARMACEUTICALS, INC.92,624$284K
NRIXNurix Therapeutics, Inc.18,250$283K
ATAIAtai Beckley N.V.75,255$266K
ZBIOZenas BioPharma, Inc.13,526$264K
ARDXARDELYX, INC.43,521$261K
CTMXCytomX Therapeutics, Inc.55,068$259K
IOVAIOVANCE BIOTHERAPEUTICS, INC.73,106$257K
XERSXeris Biopharma Holdings, Inc.42,245$245K
PGENPRECIGEN, INC.62,789$243K
HROWHARROW, INC.6,573$232K
ORICOric Pharmaceuticals, Inc.17,809$226K
BCAXBicara Therapeutics Inc.11,244$224K
OLMAOlema Pharmaceuticals, Inc.14,225$212K
ALVOAlvotech58,612$201K
SVRASavara Inc36,107$197K
TECXTectonic Therapeutic, Inc.6,332$196K
GHRSGH Research PLC13,507$190K
ABCLAbCellera Biologics Inc.53,798$188K
QUREuniQure N.V.11,054$181K
KALVKalVista Pharmaceuticals, Inc.8,970$181K
GRFSGrifols S.A.21,649$174K
GERNGERON CORP113,281$169K
ARVNARVINAS, INC.14,950$158K
ABUSArbutus Biopharma Corp34,129$154K
CGEMCullinan Therapeutics, Inc.10,484$149K
MESOMesoblast Limited9,290$143K
SPRYARS Pharmaceuticals, Inc.17,541$141K
SANASana Biotechnology, Inc.47,269$136K
BIOABioAge Labs, Inc.7,707$135K
ZURAZura Bio Ltd21,600$129K
ABSIAbsci Corporation42,685$128K
KURAKura Oncology, Inc.15,442$126K
PVLAPALVELLA THERAPEUTICS, INC.1,000$125K
ESPREsperion Therapeutics, Inc.42,424$116K
SLDBSolid Biosciences Inc.13,826$100K
ZVRAZEVRA THERAPEUTICS, INC.9,990$93K
PRTAPROTHENA CORP PUBLIC LTD CO9,553$93K
CMPSCOMPASS Pathways plc16,735$93K
BHVNBiohaven Ltd.10,800$91K
IVVDInvivyd, Inc.69,178$90K
AQSTAquestive Therapeutics, Inc.21,650$90K
IVAInventiva S.A.16,000$89K
LRMRLarimar Therapeutics, Inc.19,270$87K
UPBUpstream Bio, Inc.9,590$86K
TRDAEntrada Therapeutics, Inc.6,794$86K
FDMT4D Molecular Therapeutics, Inc.9,052$84K
LYELLyell Immunopharma, Inc.3,770$76K
RGNXREGENXBIO Inc.8,983$75K
SRZNSurrozen Inc.2,500$73K
CAMPCamp4 Therapeutics Corp16,000$71K
RCKTRocket Pharmaceuticals Inc.19,266$69K
ALTAltimmune, Inc.22,223$68K
SIGASIGA TECHNOLOGIES INC12,708$68K
CADLCandel Therapeutics, Inc.12,998$64K
KROSKeros Therapeutics, Inc.5,406$60K
PBYIPUMA BIOTECHNOLOGY, INC.9,028$58K
NGNENeurogene Inc.2,749$55K
LENZLENZ Therapeutics, Inc.5,553$51K
AVXLANAVEX LIFE SCIENCES CORP.16,445$50K
AUTLAutolus Therapeutics plc35,597$49K
ACIUAC Immune SA17,852$49K
NBPNovaBridge Biosciences19,919$49K
CCCCC4 Therapeutics, Inc.17,316$46K
CHRSCoherus Oncology, Inc.26,525$45K
SLNSilence Therapeutics Plc8,335$44K
VYGRVoyager Therapeutics, Inc.10,458$40K
BCYCBICYCLE THERAPEUTICS PLC8,222$38K
DMACDiaMedica Therapeutics Inc.5,000$34K
PRQRProQR Therapeutics N.V.20,000$32K
SGMTSagimet Biosciences Inc.5,501$29K
MENSJyong Biotech Ltd.13,173$28K
BDTXBlack Diamond Therapeutics, Inc.10,111$22K
HUMAHumacyte Inc.34,249$21K
AARDAardvark Therapeutics, Inc.3,864$15K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.